Ocular metastasis is the most common intraocular malignancy.1,2 Cutaneous melanoma accounts for 2% of ocular metastatic disease1,2; they tend to be bilateral, large, flat, and multifocal.2 The 5-year survival rate for cutaneous melanoma metastatic to the eye was 33% in a large cohort analysis.2
A 67-year-old man was referred for bilateral mild blurry vision and floaters. His medical history was significant for metastatic cutaneous melanoma with BRAF (B-Raf proto-oncogene) V600K mutation. Ophthalmologic examination showed multiple, diffuse, nonelevated, pigmented choroidal lesions in both eyes (Figure 1, A and B). Fluorescein angiography demonstrated blockage and lack of intrinsic tumor vascularity. Optical coherence tomography showed normal overlying internal retinal layers and pigment epithelium structure without exudative or degenerative changes and minimal thickening of the choroid. Severe progression of his metastatic disease was documented with increased number and size of cutaneous, subcutaneous lesions, new-onset liver and uveal metastases when receiving systemic and intralesional immunotherapy. The patient was started on combined BRAF/MEK (Mitogen-activated protein kinase/Extracellular signal-regulated Kinase) (dabrafenib/trametinib) inhibitor treatment. After 18 months of combined targeted therapy, the choroidal lesions showed complete regression in both eyes (Figure 1, C and D) along with stable systemic disease. No ocular side effects were experienced during targeted therapy and no recurrence of choroidal lesions was documented during a 9-month follow-up. Based on a systematic literature review (PubMed and Google Scholar), this seems to be the first documented case of regression of uveal metastasis with combined targeted therapy.
Fig. 1.
Diffuse, multifocal, pigmented choroidal metastases in the right (A) and left eye (B) of a patient with cutaneous melanoma. Complete regression of uveal metastases in response to combined BRAF/MEK inhibitor therapy (right eye, C; left eye, D).
Treatment of uveal metastasis may be required if the metastatic lesion seems chemotherapy-resistant and vision or globe-threatening.1 Shields et al reported spontaneous regression of uveal metastasis of cutaneous melanoma3 and others found resolved choroidal metastatic lesions from melanoma in response to chemotherapy (carmustin, cisplatin).4,5 Our case indicated that combined BRAF and MEK inhibition may provide a benefit in the treatment of uveal metastasis from cutaneous melanoma.
Footnotes
None of the authors has any financial/conflicting interests to disclose.
The authors thank the patient for granting permission to publish his case.
RETINA® is now accepting manuscripts for consideration for publication in the Photo Essay section. For a manuscript to be considered for publication within this section, the significance of the manuscript should revolve around the photographs. The photographs should convey an important or unique clinical diagnosis, condition, or treatment. The photographs can be a combination of kodachromes, angiograms, histologic sections, or ancillary diagnostic studies (e.g., echograms, radiograms, CT or MRI studies, arteriograms), all of which are imperative in the evaluation, diagnosis, and/or treatment of the condition that is represented. Overall, the Photo Essay manuscript will be limited to 300 words, five photographs, and five references. All figures submitted in color will be published in color at the expense of the authors. Please refer to the Author Instructions for all other general requirements of manuscripts submitted to RETINA®.
Contributor Information
Adrienne Csutak, Email: csutak.adrienne@pte.hu.
Zsuzsanna Lengyel, Email: lengyel.zsuzsanna@pte.hu.
References
- 1.Shields CL, Shields JA, Gross NE, et al. Survey of 520 eyes with uveal metastases. Ophthalmology 1997;104:1265–1276. [DOI] [PubMed] [Google Scholar]
- 2.Shields CL, Welch RJ, Malik K, et al. Uveal metastasis: clinical features and survival outcome of 2214 tumors in 1111 patients based on primary tumor origin. Middle East Afr J Ophthalmol 2018;25:81–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Shields CL, Piccone MR, Fung KL, Shields JA. Spontaneous regression of metastatic cutaneous melanoma to the choroid. Retina 2002;22:806–808. [DOI] [PubMed] [Google Scholar]
- 4.Stark WJ, Rosenthal AR, Mullins GM, Green WR. Simultaneous bilateral uveal melanomas responding to BCNU therapy. Trans Am Acad Ophthalmol Otolaryngol 1971;75:70–83. [Google Scholar]
- 5.Nicolo M, Calabria G. Choroidal metastasis from a cutaneous malignant melanoma regressed after cisplatin therapy. Retina 2004;24:622–624. [DOI] [PubMed] [Google Scholar]